Market Growth & Outlook
The Cell Lysis and Disruption Market is experiencing strong growth driven by the rapid expansion of biopharmaceutical manufacturing, genomics, and proteomics research. As demand for monoclonal antibodies, therapeutic proteins, and vaccines increases, reliable cell disruption methods have become indispensable for efficient downstream processing.
Additionally, neuroscience and single-cell analysis applications are fueling demand for minimal-loss and high-fidelity cell lysis. Innovations in automation and high-throughput cell disruption techniques are helping laboratories scale operations, which is further solidifying market momentum.
2 Views
